Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity.
By K. Hida, J. Wada, Jun Eguchi, Hong Zhang, Masako Baba, Aya Seida, Izumi Hashimoto, Tatsuo Okada, Akihiro Yasuhara, A. Nakatsuka and 9 more. Proceedings of the National Academy of Sciences of the United States of America, 2005
765 citations recorded by the source corpus.
Subfields: Epidemiology, Molecular Biology, Physiology
View Paper: https://www.semanticscholar.org/paper/c43e57327bf8572f182f58614b510982dab4738c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Molecular Biology
In Physiology
Citations in the corpus
- An overview of the serpin superfamily (2006, background): “SERPINA11 XP_170754.3 Not characterized SERPINA12 Vaspin Extracellular; insulin-sensitizing adipocytokine [ 71 ] SERPINA13 XM_370772 Not characterized SERPINB1 Monocyte neutrophil elastase Intracellular; inhibition of neutrophil elastase [72] inhibitor”
- Adipokines as emerging mediators of immune response and inflammation (2007, background): “as a serpin (serine protease inhibitor) that was produced in visceral adipose tissue”
- Adipocytokines: mediators linking adipose tissue, inflammation and immunity (2006, background): “Preliminary studies indicate that VASPIN might also have anti-inflammatory effects, as it suppresses the production of TNF, leptin and resisti”
- Adipokines: the missing link between insulin resistance and obesity. (2008, background): “[90] Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, et al.”